'Acute vte' presentation slideshows

749 views • 54 slides

A Randomized Trial of Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism

A Randomized Trial of Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism. Schulman S et al. Proc ASH 2011;Abstract 205. Background.

155 views • 8 slides

RE-COVER

RE-COVER. Primary outcome (recurrent VTE or death due to VTE): 2.4% vs. 2.1% Mortality: 1.6% vs. 1.7% (p > 0.05) Major bleeding: 1.6% vs. 1.9%; Major + clinically relevant bleeding: 5.6% vs. 8.8.% (p = 0.002). (p = 0.38). (p < 0.001*).

122 views • 1 slides